SEOUL, July 2 (Yonhap) -- South Korean shares opened higher Thursday, led by pharmaceuticals.
The benchmark Korea Composite Stock Price Index (KOSPI) rose 12.86 points, or 0.61 percent, to 2,119.56 in the first 15 minutes of trading.
SK Biopharmaceuticals Co. Ltd., the largest IPO offering of the year so far, spiked 29.59 percent on the day of its debut.
Top pharmaceutical firm Samsung BioLogics surged 4.26 percent, with Celltrion spiking 3.87 percent.
Most large caps were in positive terrain.
Market bellwether Samsung Electronics stayed flat, while No. 2 chipmaker SK hynix lost 0.82 percent.
Internet giant Naver and its rival Kakao both added 1.86 percent, and leading chemical maker LG Chem climbed 0.10 percent.
The local currency was trading at 1,201.80 won against the U.S. dollar, up 1.60 won from the previous session's close.
(News Focus) S. Korea drums up measures to revive consumption, create jobs next year amid pandemic
S. Korean companies bet big on hydrogen for zero-emission goal
S. Koreans feel pinch of rising housing costs amid economic downturn
Korean Air's Asiana takeover heralds seismic shift; bumpy roads lie ahead for completion
(News Focus) Biden's victory heralds more multilateral approach, environment, pro-labor policies in focus